IDEXX Laboratories, Inc. (IDXX)

NASDAQ: IDXX · Real-Time Price · USD
433.28
+0.28 (0.06%)
Nov 8, 2024, 4:00 PM EST - Market closed
0.06%
Market Cap 35.48B
Revenue (ttm) 3.84B
Net Income (ttm) 866.24M
Shares Out 81.88M
EPS (ttm) 10.36
PE Ratio 41.83
Forward PE 37.15
Dividend n/a
Ex-Dividend Date n/a
Volume 600,284
Open 430.01
Previous Close 433.00
Day's Range 428.75 - 434.48
52-Week Range 404.74 - 583.39
Beta 1.36
Analysts Buy
Price Target 545.29 (+25.85%)
Earnings Date Oct 31, 2024

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos... [Read more]

Sector Healthcare
IPO Date Jun 21, 1991
Employees 11,000
Stock Exchange NASDAQ
Ticker Symbol IDXX
Full Company Profile

Financial Performance

In 2023, IDEXX Laboratories's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $545.29, which is an increase of 25.85% from the latest price.

Price Target
$545.29
(25.85% upside)
Analyst Consensus: Buy
Stock Forecasts

News

IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participan...

9 days ago - Seeking Alpha

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating pr...

9 days ago - Business Wire

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth

Idexx Laboratories Inc IDXX reported third-quarter adjusted EPS of $2.79, up 12% year-over-year, beating the consensus of $2.68.

9 days ago - Benzinga

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

IDEXX Laboratories trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits to veterinary clinics from pet owners.

10 days ago - Reuters

IDEXX Laboratories Announces Third Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company repor...

10 days ago - Business Wire

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, Octo...

5 weeks ago - Business Wire

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...

2 months ago - Business Wire

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

IDEXX reported lower full-year organic revenue growth due to reduced U.S. clinical visits. Weak consumer sentiment and ongoing staffing challenges may continue to impact clinical visits in the near fu...

3 months ago - Seeking Alpha

Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

Tuesday, Idexx Laboratories Inc IDXX reported second-quarter adjusted EPS of $3.02, up 15% year-over-year, beating the consensus of $2.88.

3 months ago - Benzinga

IDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call Transcript

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participants...

3 months ago - Seeking Alpha

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company rep...

3 months ago - Business Wire

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earni...

3 months ago - Seeking Alpha

IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am E...

3 months ago - Business Wire

IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals

WESTBROOK, Maine , July 30, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published its 2023 Corporate Responsibility Report "Enhanc...

3 months ago - PRNewsWire

Looking For Fast Growth In Healthcare? IDEXX Has You Covered

IDEXX Laboratories is a $41 billion market cap giant in the diagnostics and research industry, with shares falling 13% since February. The company specializes in animal healthcare diagnostics, showing...

4 months ago - Seeking Alpha

IDEXX Laboratories to Release 2024 Second Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, Augu...

4 months ago - Business Wire

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 minut...

5 months ago - PRNewsWire

IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financia...

6 months ago - Business Wire

IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar

IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visits ...

6 months ago - Reuters

IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company repor...

6 months ago - Business Wire

How to trade Fed news, plus stocks to consider

The Federal Reserve has entered a two-day meeting that will end with an announcement about its decision regarding interest rates. In the meantime, debate on Wall Street has been raging over how, when,...

Other symbols: FCX
6 months ago - Yahoo Finance

IDEXX Laboratories to Release 2024 First Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May...

7 months ago - Business Wire

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 29, 10:50 am ...

9 months ago - Business Wire

IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect

Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits WESTBROOK, Maine , Feb. 15, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global lead...

9 months ago - PRNewsWire

IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript

IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript

9 months ago - Seeking Alpha